About the Authors

Javiera Cortés-Ríos

Roles Conceptualization, Formal analysis, Investigation, Methodology, Software, Writing – original draft, Writing – review & editing

fabian.frohlich@crick.ac.uk (FF); jacortes4@uc.cl (JC-R)

Affiliations Institute for Biological and Medical Engineering, Schools of Engineering, Medicine and Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile, Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, New York, United States of America

Maria Rodriguez-Fernandez

Roles Funding acquisition, Project administration, Writing – review & editing

Affiliation Institute for Biological and Medical Engineering, Schools of Engineering, Medicine and Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile

Peter Karl Sorger

Roles Conceptualization, Funding acquisition, Project administration, Writing – review & editing

Affiliation Laboratory of Systems Pharmacology and Department of Systems Biology, Harvard Medical School, Boston, Massachusetts, United States of America

Fabian Fröhlich

Roles Conceptualization, Formal analysis, Methodology, Software, Supervision, Writing – original draft, Writing – review & editing

fabian.frohlich@crick.ac.uk (FF); jacortes4@uc.cl (JC-R)

Affiliation Dynamics of Living Systems Laboratory, The Francis Crick Institute, London, United Kingdom

Competing Interests

I have read the journal’s policy and the authors of this manuscript have the following competing interests: J.C.R. was a joint postdoctoral fellow within the University at Buffalo and GlaxoSmithKline (GSK). P.K.S. is a co-founder and member of the BOD of Glencoe Software and member of the SAB for RareCyte, NanoString, and Montai Health; he holds equity in Glencoe and RareCyte. Additionally, P.K.S. consults for Merck. F.F has consulted for DeepOrigin.